BIOXYTRAN, INC. Proceeds from Issuance or Sale of Equity
BIOXYTRAN, INC. (BIXT) reported Proceeds from Issuance or Sale of Equity of $63.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2025-04-03
- BIOXYTRAN, INC. proceeds from issuance or sale of equity for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOXYTRAN, INC. proceeds from issuance or sale of equity for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- BIOXYTRAN, INC. proceeds from issuance or sale of equity for the quarter ending 2024-06-30 was $59.00K, a 9.23% decline year-over-year.
- BIOXYTRAN, INC. proceeds from issuance or sale of equity for the quarter ending 2024-03-31 was $4.00K, a 92.00% decline year-over-year.
- BIOXYTRAN, INC. proceeds from issuance or sale of equity for fiscal 2024 was $63.00K, a 88.55% decline from fiscal 2023.
- BIOXYTRAN, INC. proceeds from issuance or sale of equity for fiscal 2023 was $550.36K.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | $0.00 derived: sum of 2 quarters · filed 2025-04-03 | $59.00K derived: sum of 3 quarters · filed 2025-04-03 | $63.00K 10-K · filed 2025-04-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $59.00K derived: sum of 2 quarters · filed 2024-10-29 | $63.00K 10-Q · filed 2024-10-29 | $108.00K derived: sum of 4 quarters · filed 2025-04-03 |
| 2024-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $63.00K 10-Q · filed 2024-08-14 | $108.00K derived: sum of 3 quarters · filed 2025-04-03 | $498.36K derived: sum of 4 quarters · filed 2025-04-03 |
| 2024-03-31 | $4.00K 10-Q · filed 2024-04-19 | $49.00K derived: sum of 2 quarters · filed 2025-04-03 | $439.36K derived: sum of 3 quarters · filed 2025-04-03 | $504.36K derived: sum of 4 quarters · filed 2025-04-03 |
| 2023-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | $435.36K derived: sum of 2 quarters · filed 2025-04-03 | $500.36K derived: sum of 3 quarters · filed 2025-04-03 | $550.36K 10-K · filed 2025-04-03 |
| 2023-09-30 | $390.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $455.36K derived: sum of 2 quarters · filed 2024-10-29 | $505.36K 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $115.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $50.00K 10-Q · filed 2023-05-12 | |||
| 2022-03-31 | $50.00K 10-Q · filed 2024-04-19 |